| Structure |
Chemical Name |
CAS |
MF |
 |
Moxifloxacin Impurity 37 |
1803729-19-2 |
C7H3ClF2O2 |
 |
1,3,5-Tri-O-benzoyl-2-deoxy-2-fluoro-α-D-ribofuranose |
704916-12-1 |
C26H21FO7 |
 |
Nifedipine impurity 10 |
10323-98-5 |
C13H13NO3 |
![5,5-ジメチル-2α-[(R)-カルボキシ(フェニルアセチルアミノ)メチル]チアゾリジン-4β-カルボン酸](/CAS/20211123/GIF/13057-98-2.gif) |
5,5-ジメチル-2α-[(R)-カルボキシ(フェニルアセチルアミノ)メチル]チアゾリジン-4β-カルボン酸 |
13057-98-2 |
C16H20N2O5S |
![isopropyl(4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]
pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate](/CAS/20200401/GIF/625115-54-0.gif) |
isopropyl(4,6-diamino-2-(1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]
pyridin-3-yl)pyrimidin-5-yl)(methyl)carbamate |
625115-54-0 |
C22H23FN8O2 |
 |
Atracurium Impurity A |
2724465-40-9 |
C28H39NO7 |
 |
Palonosetron Impurity TM1-RR |
1022895-91-5 |
C15H23ClN2 |
 |
4-(2-HYDROXY-3-ISOPROPYLAMINO-PROPOXY)-BENZOIC ACID METHYL ESTER |
33947-97-6 |
C14H21NO4 |
 |
Fosaprepitant Impurity 8 |
|
|
 |
(R,E)-7-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)-3-hydroxy-5-oxohept-6-enoic acid |
1422514-05-3 |
C22H26FN3O6S |
 |
Anastrozole iMpurity F |
|
|
 |
デヒドロニトロソニソルジピン |
87375-91-5 |
C20H22N2O5 |
 |
2-Desisopropyl-2-phenyl Repaglinide |
107362-12-9 |
C30H34N2O4 |
 |
Lenvatinib impurity LFZZ-17 |
|
C11H9NO4 |
![2-[4-(2,3-DIHYDROXYPROPOXY)PHENYL]ACETAMIDE](/CAS/GIF/61698-76-8.gif) |
2-[4-(2,3-DIHYDROXYPROPOXY)PHENYL]ACETAMIDE |
61698-76-8 |
C11H15NO4 |
 |
Amoxicillin Impurity N(EP) |
|
|
 |
Nilotinib N-Oxide Impurity 3 |
|
|
 |
α-Decitabine |
22432-95-7 |
C8H12N4O4 |
![N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole](/CAS/GIF/957470-59-6.gif) |
N-[(3,4-DiMethoxy-2-pyridinyl)Methyl] Pantoprazole |
957470-59-6 |
C24H24F2N4O6S |
 |
Tofacitinib Impurity 112 |
2179757-75-4 |
C12H19N3O2 |
 |
(R)-カルビドーパ |
28875-92-5 |
C10H14N2O4 |
 |
Topiroxostat Impurity 18 |
|
|
![(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine](/CAS/20200401/GIF/CB85422885.gif) |
(3S,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-1-methyl-4-phenylpiperidine |
|
C20H23NO3 |
 |
Zopiclone Impurity 12 |
|
|
 |
Olanzapine impurity N |
|
C17H20N4S |
 |
Oseltamivir Impurity 85 |
|
|
![Benzeneacetic acid, 3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-, methyl ester](/CAS/20211123/GIF/1187954-56-8.gif) |
Benzeneacetic acid, 3-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-α,α-dimethyl-, methyl ester |
1187954-56-8 |
C33H41NO4 |
 |
Tazobactam Impurity EBT |
|
|
 |
Roxithromycin Impurity E |
|
|
 |
Fluorometholone Impurity |
2796-99-8 |
C23H31FO7S |
 |
Gliclazide Impurity E |
|
|
 |
Paroxetine EP IMpurity G |
69675-10-1 |
C12H14FN |
 |
Dapagliflozin Impurity 2 |
|
|
 |
Flomoxef oxidation impurities |
|
|
 |
SofosBuvir Impurity 51 |
|
|
 |
Peramivir Intermediate Impurity 37 |
|
|
 |
N,O-Dibenzylated formoterol |
43229-70-5 |
C33H36N2O4 |
 |
(2S,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)-3,4,5-Piperidinetriol Hydrochloride |
1370331-33-1 |
C8H17NO5 |
 |
Ivabradine Impurity 5 |
1462470-54-7 |
C27H38N2O6 |
![1-[4-(4-アミノ-6,7-ジメトキシ-2-キナゾリニル)-1-ピペラジニル]-2-ヒドロキシ-1-ペンタノン](/CAS/GIF/152551-75-2.gif) |
1-[4-(4-アミノ-6,7-ジメトキシ-2-キナゾリニル)-1-ピペラジニル]-2-ヒドロキシ-1-ペンタノン |
152551-75-2 |
C19H27N5O4 |
 |
4-Pyrimidineethanol, 6-bromo-α-(2,4-difluorophenyl)-5-fluoro-β-methyl-α-(1H-1,2,4-triazol-1-ylmethyl)- |
1307315-04-3 |
C16H13BrF3N5O |
 |
Montelukast iMpurity |
2734125-88-1 |
|
![1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-](/CAS/20210111/GIF/2138805-26-0.gif) |
1H-Purine-2,6-dione, 8-(3-amino-1-piperidinyl)-7-(3-chloro-2-buten-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
2138805-26-0 |
C25H29ClN8O2 |
 |
(R)-3-(4-(5-broMo-2-chlorobenzyl)phenoxy)tetrahydrofuran |
915095-90-8 |
C17H16BrClO2 |
 |
(R)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-(hydroxymethyl)phenyl propionate |
|
C25H35NO3 |
 |
Cefathiamidine Impurity 8 |
|
|
![(6R,7S)-3-メチル-8-オキソ-7β-[(フェニルアセチル)アミノ]-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸](/CAS/GIF/27255-72-7.gif) |
(6R,7S)-3-メチル-8-オキソ-7β-[(フェニルアセチル)アミノ]-5-チア-1-アザビシクロ[4.2.0]オクタ-2-エン-2-カルボン酸 |
27255-72-7 |
C16H16N2O4S |
 |
L-グルコノ-1,5-ラクトン |
52153-09-0 |
C6H10O6 |
 |
oxiracetaM related substance ISF3886 |
120428-80-0 |
C8H13N3O4 |
 |
Tofacitinib Impurity 3 |
1206825-36-6 |
C13H19N5 |
 |
Paxlovid Impurity 17 |
|
|
 |
3-Bromo Carbidopa |
1246819-09-9 |
C10H13BrN2O4 |
 |
L-イソロイシン酸アシクロビル |
142963-63-1 |
C14H22N6O4 |
 |
3-amino-2-chloroacrolein |
221615-73-2 |
C3H4ClNO |
 |
Mupirocin Impurity E |
|
C26H44O9 |
![IMp. C (EP): 8-Chloro-11-(piperazin-1-yl)-5H- dibenzo[b,e][1,4]diazepine](/) |
IMp. C (EP): 8-Chloro-11-(piperazin-1-yl)-5H- dibenzo[b,e][1,4]diazepine |
|
|
![1-[[2-[(2-AMinophenyl)aMino]-5-Methyl-3-thienyl]carbonyl]-4-Methyl-piperazine](/CAS/GIF/138564-61-1.gif) |
1-[[2-[(2-AMinophenyl)aMino]-5-Methyl-3-thienyl]carbonyl]-4-Methyl-piperazine |
138564-61-1 |
C17H22N4OS |
 |
Zolmitriptan Impurity 2 |
|
|
 |
Aprepitant Impurity 18 |
|
|
 |
Brivaracetam Impurity E |
|
|
 |
Oxacillin sodium Impurity I |
|
|
 |
Irbesartan Impurity 15 |
|
C25H28N6O |
 |
Iguratimod |
123663-50-3 |
C18H16N2O6S |
 |
(3S,4R)-4-(4-Fluorophenyl)piperidine-3-Methanol Hydrochloride |
220548-73-2 |
C12H17ClFNO |
 |
Brivaracetam Impurity 62 |
|
|
 |
AZD9291 Osimertinib Impurity 1 |
|
|
 |
Rocuronium Bromide Impurity 32 、33 |
|
|
 |
Vonoprazan Impurity 2 |
881733-36-4 |
C17H16FN3O2S |
 |
21-(アセチルオキシ)-17-ヒドロキシ-16α-メチルプレグナ-1,4,9(11)-トリエン-3,20-ジオン |
10106-41-9 |
C24H30O5 |
![(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one](/CAS/20180703/GIF/1288338-96-4.gif) |
(R)-1-[3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]-3-chloropropan-1-one |
1288338-96-4 |
C25H25ClN6O2 |
 |
Ivabradine Impurity 15 |
1132667-04-9 |
C12H17NO2 |
 |
Bis(4-fluorobenzyl)aMine, 97% |
134227-41-1 |
C14H13F2N |
 |
Levosimendan Impurity 2 |
103416-88-2 |
C11H12N2O2 |
 |
Pidotimod Impurity N |
1538596-97-2 |
C15H23N5O2S |
 |
Ibrutinib Impurity 17 |
2134109-10-5 |
C16H18N6O |
 |
Pramipexole 828 Impurity |
|
|
 |
Pitavastatin Impurity 49 |
|
|
 |
CLARITHROMYCIN OXIME |
127253-06-9 |
C38H70N2O13 |
 |
Valsartan related compound H |
|
|
 |
Peramivir Deacetylated Impurity |
|
|
 |
NA |
|
|
 |
Sitafloxacin Dechloro Impurity |
|
|
 |
Paroxetine EP Impurity H HCl |
503834-41-1 |
C19H23ClFNO |
![Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)](/CAS/GIF/72901-16-7.gif) |
Bisacodyl Related Compound C (20 mg) (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
72901-16-7 |
C20H17NO3 |
 |
AMIKACIN IMPURITY A |
|
|
 |
Decitabine iMpurity 5 |
|
|
 |
Prucalopride Impurity C |
1599434-55-5 |
C17H24ClN3O3 |
 |
Rosuvastatin Substituted Hydroxy Pentenoic Acid |
910867-11-7 |
C20H24FN3O5S |
 |
Uridine, 5'-(2-methylpropanoate) (9CI) |
886538-48-3 |
C13H18N2O7 |
![(1R,3S)-3-[2-アミノ-6-(シクロプロピルアミノ)-9H-プリン-9-イル]シクロペンタンメタノール](/CAS/GIF/208762-35-0.gif) |
(1R,3S)-3-[2-アミノ-6-(シクロプロピルアミノ)-9H-プリン-9-イル]シクロペンタンメタノール |
208762-35-0 |
C14H20N6O |
 |
Vonoprazan Impurity F |
|
|
 |
Diacerein IMpurity F |
13928-72-8 |
C35H36O16 |
 |
Ezetimibe Impurity 33 |
1829558-53-3 |
C13H10FNO |
 |
7-ADCA Impuirty 1 |
|
|
 |
Ranitidine Impurity D |
|
C13H22N4O3S |
 |
α-アミノ-3',4'-ジヒドロキシアセトフェノン |
499-61-6 |
C8H9NO3 |
 |
PF 2825 |
153012-65-8 |
C21H28N2O5S |
 |
Linagliptin Impurity 58 |
|
|
![2-アミノ-N-[(1α,4β)-4-ヒドロキシシクロヘキシル]ベンズアミド](/CAS/GIF/15942-11-7.gif) |
2-アミノ-N-[(1α,4β)-4-ヒドロキシシクロヘキシル]ベンズアミド |
15942-11-7 |
C13H18N2O2 |
 |
Peramivir Impurity 57 |
|
|